Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303
Clinical trial NCT05208866 · TERMINATED
Trial details
- NCT number
- NCT05208866
- Sponsor
- Palladio Biosciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-10
- Primary completion
- 2022-06-29
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.